# Signatur Biosciences

Source: https://onco.cc/companies/signatur-biosciences/  
OnCo record `signatur-biosciences` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Signatur turns complex gene-expression tests, starting with breast cancer prognosis, into simple PCR tests that a local hospital lab can run in days.

## Summary

Signatur Biosciences develops decentralised precision diagnostics that translate multi-gene expression signatures into PCR-based assays runnable in local hospital laboratories, with a first product for early breast cancer prognosis to guide chemotherapy decisions, cutting turnaround from weeks in a centralised laboratory to days at a fraction of the cost. The company is London-based and remains active in the YC directory; clinical validation data have not been published in a primary source found at the time of checking.

## Fields

- Kind: Company
- Last checked: 2026-09-10
- Tags: yc
- HQ: London
- Type: diagnostics
- Website: https://www.signatur.bio

## Sources

- Y Combinator profile: https://www.ycombinator.com/companies/signatur-biosciences
- Official website: https://www.signatur.bio

## Connected records

- cancers: [HR-positive / HER2-negative breast cancer](https://onco.cc/cancers/breast-hr-positive/)
- fronts: [Diagnostics & Biomarkers](https://onco.cc/fronts/diagnostics/)
- technologies: [Companion diagnostics](https://onco.cc/technologies/companion-diagnostic/)
- companies: [Y Combinator](https://onco.cc/companies/y-combinator/)

---
JSON: https://onco.cc/api/v1/entities/signatur-biosciences.json